BioLife Solutions to be acquired by Repligen in $1.5B cell therapy deal

BioLife Solutions to be acquired by Repligen in $1.5B cell therapy deal

BioLife Solutions to be acquired by Repligen in $1.5B cell therapy deal Lisa Stiffler Roderick de Greef, CEO of BioLif…

By -